Novem Group Takes Position in UnitedHealth Group Incorporated (NYSE:UNH)

Novem Group acquired a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to the company in its most recent filing with the SEC. The fund acquired 1,689 shares of the healthcare conglomerate's stock, valued at approximately $854,000.

Other large investors also recently modified their holdings of the company. NewSquare Capital LLC acquired a new position in UnitedHealth Group during the 4th quarter worth $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new stake in UnitedHealth Group in the fourth quarter valued at about $26,000. Hurley Capital LLC acquired a new stake in UnitedHealth Group during the fourth quarter valued at approximately $28,000. AlphaMark Advisors LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $30,000. Finally, Aster Capital Management DIFC Ltd bought a new position in UnitedHealth Group during the fourth quarter worth $30,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research analysts have recently commented on UNH shares. Truist Financial reaffirmed a "buy" rating and issued a $360.00 price target (down from $580.00) on shares of UnitedHealth Group in a report on Monday. TD Securities reiterated a "hold" rating and set a $308.00 price target (down from $520.00) on shares of UnitedHealth Group in a research report on Monday. Argus lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Monday, April 21st. StockNews.com upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. Finally, JPMorgan Chase & Co. decreased their target price on shares of UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating for the company in a research report on Thursday, May 15th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, UnitedHealth Group has an average rating of "Moderate Buy" and a consensus price target of $441.87.

Insider Buying and Selling

In related news, Director John H. Noseworthy acquired 300 shares of the company's stock in a transaction on Wednesday, May 14th. The shares were purchased at an average price of $312.16 per share, for a total transaction of $93,648.00. Following the purchase, the director now owns 6,063 shares in the company, valued at $1,892,626.08. This represents a 5.21% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Timothy Patrick Flynn purchased 1,533 shares of the company's stock in a transaction dated Wednesday, May 14th. The stock was bought at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the purchase, the director now directly owns 6,033 shares of the company's stock, valued at $1,935,386.40. The trade was a 34.07% increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders acquired 109,408 shares of company stock valued at $31,607,768. Corporate insiders own 0.33% of the company's stock.

UnitedHealth Group Stock Down 5.8%

UNH stock opened at $303.08 on Thursday. The firm has a market cap of $274.93 billion, a PE ratio of 19.55, a P/E/G ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The firm has a 50 day simple moving average of $460.62 and a 200 day simple moving average of $508.74. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period in the prior year, the business posted $6.91 EPS. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 2.77%. UnitedHealth Group's dividend payout ratio (DPR) is presently 35.18%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.